$491M Investments, $2152M Value Returned To Investors,
We have a history of exceptional returns on investment. In the last 15 years, thanks to our deep expertise in next-generation biomedical technologies, such as gene therapy, advanced cell therapy, nanotechnology, bionics, AI, and big data the team has returned, in aggregate, over $1.5Bn to investors with a 4.5x aggregate investment multiple.
Join us in shaping a world where every disease can be cured, prevented or managed.
